Larvol Delta - Ankyra-Therapeutics-Announces-Clinical-Trial-Supply-Agreement-with-Regeneron-to-Evaluate-ANK101-in-Combination-with-Libtayo-cemiplimab-in-Patients-with-Cutaneous-Squamous-Cell-Carcinoma

ANK-101 - Ankyra Therap

https://www.businesswire.com/news/home/20231113987220/en/Ankyra-Therapeutics-Announces-Clinical-Trial-Supply-Agreement-with-Regeneron-to-Evaluate-ANK-101-in-Combination-with-Libtayo%C2%AE-cemiplimab-in-Patients-with-Cutaneous-Squamous-Cell-Carcinoma

Nov 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next